HarrisH, and WatkinsJF: Hybrid cells derived from mouse and man: artificial heterokaryons of mammalian cells from different species. Nature, 1965; 205:640–646.
2.
DavidsonRL, EphrussiB, and YamamotoK: Regulation of pigment synthesis in mammalian cells, as studied by somatic hybridization. Proc Natl Acad Sci USA, 1966; 56:437–1440.
3.
WeissM, and GreenH: Human-mouse hybrid cell lines containing partial complements of human chromosomes and functioning human genes. Proc Natl Acad Sci USA, 1967; 58:1104–1111.
4.
SteplewskiZ, KnowlesBB, and KoprowkiH: The mechanism of internuclear transmission of SV40-induced complement fixation antigen in heterokaryocytes. Proc Natl Acad Sci USA, 1968; 59:769–776.
5.
KnowlesBB, JensenFC, SteplewskiZ, and KoprowskiH: Rescue of infectious SV40 after fusion between different SV40- transformed cells. Proc Natl Acad Sci USA, 1968; 61:42–45.
6.
CoffinoP, KnowlesBB, ScharffM, and NathansonS: Suppression of immunoglobulin synthesis by cellular hybridization. Nature New Biol, 1971; 231:87–90.
7.
KanoK, KnowlesBB, KoprowskiH, and MilgromF: HL-A antigens on man-mouse hybrid cells. Eur J Immunol, 1972; 2:197–202.
8.
TrinchieriG, AdenD, and KnowlesBB: Cell-mediated cytotoxicity to SV40-specific tumor-associated antigens. Nature, 1976; 261:312–314.
9.
YeX, McCarrickJ, JewettL, and KnowlesBB: Timely immunization subverts the development of peripheral nonresponsivenes and suppresses tumor development in SV40 T antigen-transgenic mice. Proc Natl Acad Sci USA, 1994; 91:3916–3920.
10.
ArtztK, DuboisP, BennettD, CondomineH, BabinetC, and JacobF: Surface antigens common to mouse cleave embryos and primitive teratocarcinoma cells in culture. Proc Natl Acad Sci USA, 1973; 70:2988–2992.
11.
KöhlerG, and MilsteinC: Continuous cultures of fused cells secreting antibody of predefined specificity. Nature, 1975; 256:495–497.
12.
StevensLC: The development of transplantable teratocarcinomas from intratesticular grafts of pre- and postimplantation mouse embryos. Develop Biol, 1970; 21:364–382.
13.
BernstineEG, HooperML, GrandchampS, and EphrussiB: Alkaline phosphatase activity in mouse teratoma. Proc Natl Acad Sci USA, 1973; 70:3899–3903.
14.
KemlerR, BabinetC, EisenH, and JacobF: Surface antigen in early differentiation. Proc Natl Acad Sci USA, 1977; 74:4449–4452.
15.
SolterD, and KnowlesBB: Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc Natl Acad Sci USA, 1978; 75:5565–5569.
16.
GooiHC, FeiziT, KapadiaA, KnowlesBB, SolterD, and EvansMJ: Stage-specific embryonic antigen (SSEA-1) involves the a1-3-fucosylated type 2 precursor chain. Nature, 1981; 292:156–158.
17.
MartinGR: Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci, 1981; 78:7634–7638.
18.
AndrewsPW, BronsonDL, BenhamF, StricklandS, and KnowlesBB: A comparative study of eight testicular teratocarcinoma cell lines. Int J Cancer, 1980; 26:269–280.
19.
AndrewsPW, GoodfellowPM, ShevinskyLH, BronsonDL, and KnowlesBB: Cell surface antigens of a clonal human embryonal carcinoma cell line: morphological and antigenic differentiation in culture. Int J Cancer, 1982; 29:523–531.
20.
ShevinskyLH, KnowlesBB, DamjanovI, and SolterD: Monoclonal antibody to murine embryos defines a stage-specific embryonic antigen expressed on mouse embryos and human teratocarcinoma stem cells. Cell, 1982; 30:697–705.
21.
KannagiR, CochranNA, IshigamiF, HakamoriS-I, AndrewsPW, KnowlesBB, and SolterD: Stage-specific antigens (SSEA-3 and -4) are epitopes of a unique globo-series ganglioside isolated from human teratocarcinoma cells. EMBO J, 1983; 2:2355–2361.
22.
HendersonJK, DraperJS, BallieHS, FishelS, ThomsonJA, MooreH, and AndrewsPW: Preimplantation human embryos and embryonic stem cells show comparable expression of stage-specific embryonic antigens. Stem Cells, 2002; 20:329–337.
23.
AndrewsPW, BantingGS, DamjanovI, ArnaudD, and AvnerP: Three monoclonal antibodies defining distinct differentiation antigens associated with different high molecular weight polypeptides on the surface of human embryonal carcinoma cells. Hybridoma, 1984; 3:347–361.
24.
AndrewsPW, MeyerLJ, BednarzK, and HarrisH: Two monoclonal antibodies recognizing determinants on human embryonal carcinoma cells react specifically with the liver isozyme of human alkaline phosphatase. Hybridoma, 1984; 3:33–39.
25.
ThomsonJA, KalishmanJ, GolosTG, DurningM, HarrisCP, BeckerRA, and HearnJ: Isolation of a primate embryonic stem cell line. Proc Natl Acad Sci USA, 1995; 92:7844–7849.
26.
ThomsonJA, Itskovitz-EldorJ, ShapiroSS, WaknitzMA, SwiergielJJ, MarshallVS, and JonesJM: Embryonic stem cell lines derived from human blastocysts. Science, 1998; 282:1145–1147.
27.
International Stem Cell Banking Initiative: Consensus guidance for banking and supply of human embryonic stem cell lines for research purposes. Stem Cell Rev Rep, 2009; 5:301–314.
28.
International Stem Cell Initiative: Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nature Biotechnol, 2007; 25:803–814.
29.
International Stem Cell Initiative: Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nature Biotechnol, 2011; 29:1132–1144.
30.
AveryS, HirstAJ, BakerD, LimCY, AlagaratnamS, SkotheimRI, LotheRA, PeraMR, ColmanA, RobsonP, AndrewsPW, and KnowlesBB: BCL-XL mediates the strong selective advantage of a 20q11.21 amplification commonly found in human embryonic stem cell cultures. Stem Cell Reports, 2013; 1:379–386.
31.
HannaJ, ChangAW, SahaK, KimJ, LegnerCJ, SoldnerF, CassidyJP, MuffatJ, CareyBW, and JaenischR: Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proc Natl Acad Sci USA, 2010; 107:9222–9227.
